We are monitoring the impact of COVID-19 & Recession alarm on North America Prostate Cancer Market Get in touch with us for detailed analysis Know More
Share on

North America Prostate Cancer Market Research Report - Segmented By Diagnostic Techniques, Surgery, Radiation Therapy, Chemotherapy and Country (The U.S., Canada & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1537
Pages: 145

North America Prostate Cancer Market Size (2022 to 2027)

The size of the prostate cancer market in North America was valued at USD 21.33 billion in 2022. This value is further estimated to be growing at a CAGR of 8.97% during the forecast period and worth USD 32.77 billion by 2027. North America is the largest market for prostate cancer across the globe. This is rising as there is constant input for innovative drugs to cure the diseases. Prostate cancer is cancer that occurs in a man’s prostate. It is one of the most widespread types of cancer in men. This type of cancer generally grows gradually and initially remains limited to the prostate gland, which may not cause severe harm. Therefore, this market needs new drugs to address unmet needs, low cost, and enhanced survival time.

The market for prostate cancer in the North American region is expected to be growing due to a rise in the prostate cancer population. The prostate cancer market is also driven by the increase in the expected approval of nine late-stage pipeline products within the forecast period. In addition, there has been much growth in the prostate cancer therapeutics market over the past decade, with several products targeting advanced forms of the disease and showing greatly increased efficacy over their predecessors.

Side effects associated with cancer treatment are expected to hinder the growth rate of the North American prostate cancer market.

This research report on the North American prostate cancer market has been segmented and sub-segmented into the following categories.

By Diagnostic Techniques: 

  • Digital Rectal Exam (DRE)
  • Prostate-Specific Antigen Test (PSA)

By Surgery: 

  • Radical Prostatectomy
  • Orchidectomy
  • Trans Urethral Resection (TUR)

By Radiation Therapy: 

  • External Beam Radiation Therapy
  • Brachytherapy

By Chemotherapy: 

  • Docetaxel
  • Etoposide
  • Vinblastine
  • Carboplatin
  • Vinorelbine

By Country: 

  • The United States
  • Canada
  • Rest of North America

Geographically, the North American market is expected to dominate the global prostate cancer market during the forecast period. The presence of advanced healthcare facilities with educated medical professionals is projected to propel the market in North America to greater levels. The increased prevalence and high mortality rate of prostate cancer in the United States are the main reasons behind North America's market dominance. In addition, this region is seeing a lot of money invested in R&D to create newer immunotherapies, rising prevalence of prostate cancer, greater awareness, and targeted pharmacological therapies to treat these cancers. Prostate cancer cases are on the rise, which means there are plenty of prospects for market players. The key market participants are concentrating their R&D efforts to bring innovative and effective therapies to the market. Market players in Canada are focusing on new product launches, partnerships, mergers, acquisitions, and other growth initiatives. The U.S. FDA is taking steps to boost the growth of the cancer therapy market by approving medications that are still in the clinical stage, thereby speeding up clinical trials. In addition, Businesses and research organizations are investing in R&D. As a result, the market is rapidly expanding.

KEY MARKET PLAYERS:

A few noteworthy companies operating in the North American prostate cancer market profiled in the report are Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Diagnostic Techniques                           

                                5.1.1 Introduction           

                                5.1.2 Digital Rectal Exam (DRE)  

                                5.1.3 Prostate Specific Antigen Test (PSA)            

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product               

                                5.1.6 Market Share Analysis, By Product                

                5.2 Surgery                        

                                5.2.1 Introduction           

                                5.2.2 Radical Prostatectomy       

                                5.2.3 Orchidectomy        

                                5.2.4 Trans Urethral Resection (TUR)      

                                5.2.5 Y-o-Y Growth Analysis, By Type      

                                5.2.6 Market Attractiveness Analysis, By Type     

                                5.2.7 Market Share Analysis, By Type      

                5.3 Radiation Therapy                   

                                5.3.1 Introduction           

                                5.3.2 External Beam Radiation Therapy  

                                                5.3.2.1 3D Conformal Radiation Therapy

                                                5.3.2.2 Intensity Modulated Radiation Therapy

                                                5.3.2.3 Stereotactic Body Radiation Therapy

                                                5.3.2.4 Proton Beam Radiation Therapy

                                5.3.3 Brachytherapy      

                                                5.3.3.1 Permanent Brachytherapy

                                                5.3.3.2 Temporary Brachytherapy

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5 Market Attractiveness Analysis, By Application        

                                5.3.6 Market Share Analysis, By Application         

                5.4 Chemotherapy                         

                                5.4.1 Introduction           

                                5.4.2 Docetaxel

                                5.4.3 Etoposide

                                5.4.4 Vinblastine             

                                5.4.5 Carboplatin             

                                5.4.6 Vinorelbine            

                                5.4.7 Y-o-Y Growth Analysis, By Disease Indications          

                                5.4.8 Market Attractiveness Analysis, By Disease Indications        

                                5.4.9 Market Share Analysis, By Disease Indications         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Techniques

                                                6.1.3.3 By Surgery

                                                6.1.3.4 By Radiation Therapy

                                                6.1.3.5 By Chemotherapy

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Techniques

                                                6.1.4.3 By Surgery

                                                6.1.4.4 By Radiation Therapy

                                                6.1.4.5 By Chemotherapy

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Techniques

                                                6.1.5.3 By Surgery

                                                6.1.5.4 By Radiation Therapy

                                                6.1.5.5 By Chemotherapy

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Sanofi S.A                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GlaxoSmithKline                      

                8.3 AstraZeneca               

                8.4 AbbVie                         

                8.5 Varian Medical Systems                        

                8.6 Elekta                           

                8.7 Theragenics               

                8.8 Pfizer                            

                8.9 Novartis                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Prostate Cancer Market, By Diagnostic Techniques , From 2022 - 2027 (USD Million)
  2. North America Digital Rectal Exam (DRE) Market, By Region, From 2022 - 2027 (USD Million)
  3. North America Prostate Specific Antigen Test (PSA) Market, By Region, From 2022 - 2027 (USD Million)
  4. North America Prostate Cancer Market, By Surgery, From 2022 - 2027 (USD Million)
  5. North America Radical Prostatectomy Market, By Region, From 2022 - 2027 (USD Million)
  6. North America Orchidectomy Market, By Region, From 2022 - 2027 (USD Million)
  7. North America Trans Urethral Resection (TUR) Market, By Region, From 2022 - 2027 (USD Million)
  8. North America Prostate Cancer Market, By Radiation Therapy, From 2022 - 2027 (USD Million)
  9. North America External Beam Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  10. North America Brachytherapy Market, By Region, From 2022 - 2027 (USD Million)
  11. North America Prostate Cancer Market, By ChemoTherapy, From 2022 - 2027 (USD Million)
  12. North America Docetaxel Market, By Region, From 2022 - 2027 (USD Million)
  13. North America Etoposide Market, By Region, From 2022 - 2027 (USD Million)
  14. North America Vinblastine Market, By Region, From 2022 - 2027 (USD Million)
  15. North America Carboplatin Market, By Region, From 2022 - 2027 (USD Million)
  16. North America Vinorelbine Market, By Region, From 2022 - 2027 (USD Million)
  17. United States Prostate Cancer Market, By Diagnostic Techniques , From 2022 - 2027 (USD Million)
  18. United States Prostate Cancer Market, By Surgery, From 2022 - 2027 (USD Million)
  19. United States Prostate Cancer Market, By Radiation Therapy, From 2022 - 2027 (USD Million)
  20. United States Prostate Cancer Market, By ChemoTherapy, From 2022 - 2027 (USD Million)
  21. Canada Prostate Cancer Market, By Diagnostic Techniques , From 2022 - 2027 (USD Million)
  22. Canada Prostate Cancer Market, By Surgery, From 2022 - 2027 (USD Million)
  23. Canada Prostate Cancer Market, By Radiation Therapy, From 2022 - 2027 (USD Million)
  24. Canada Prostate Cancer Market, By ChemoTherapy, From 2022 - 2027 (USD Million)
  25. North America Prostate Cancer Market, By External Beam Radiation Therapy, From 2022 - 2027 (USD Million)
  26. North America 3D Conformal Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  27. North America Intensity Modulated Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  28. North America Stereotactic Body Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  29. North America Proton Beam Radiation Therapy Market, By Region, From 2022 - 2027 (USD Million)
  30. United States Prostate Cancer Market, By External Beam Radiation Therapy, From 2022 - 2027 (USD Million)
  31. Canada Prostate Cancer Market, By External Beam Radiation Therapy, From 2022 - 2027 (USD Million)
  32. North America Prostate Cancer Market, By Brachytherapy, From 2022 - 2027 (USD Million)
  33. North America Permanent Brachytherapy Market, By Region, From 2022 - 2027 (USD Million)
  34. North America Temporary Brachytherapy Market, By Region, From 2022 - 2027 (USD Million)
  35. United States Prostate Cancer Market, By Brachytherapy, From 2022 - 2027 (USD Million)
  36. Canada Prostate Cancer Market, By Brachytherapy, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample